サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1322021

脊髄刺激の世界市場 - 市場規模、シェア、成長分析：技術タイプ別（充電式、非充電式）、用途別（腰部手術失敗症候群、複合性局所疼痛症候群） - 業界予測（2023年～2030年）

Global Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Technology Type(Rechargeable, Non-Rechargeable), By Application(Failed back surgery syndrome, Complex Regional Pain Syndrome) - Industry Forecast 2023-2030
出版日: | 発行: SkyQuest | ページ情報: 英文 165 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脊髄刺激の世界市場 - 市場規模、シェア、成長分析：技術タイプ別（充電式、非充電式）、用途別（腰部手術失敗症候群、複合性局所疼痛症候群） - 業界予測（2023年～2030年）
出版日: 2023年07月19日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の脊髄刺激の市場規模は、2021年に30億2,000万米ドル、2022年に32億5,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に7.58％のCAGRで拡大し、2030年には58億3,000万米ドルに拡大すると予測されています。

脊髄刺激装置（SCS）は、背柱刺激装置としても知られ、慢性疼痛を治療するために体内に埋め込む神経刺激装置です。痛みの信号を遮断する電気信号を発することで機能し、脊髄、背中、腕、脚に関連する症状を緩和します。この治療法は、薬物療法や他の伝統的な治療法に反応しない慢性疼痛患者に特に有益です。

世界の脊髄刺激（SCS）市場は、技術の進歩、SCS手技に関するガイドラインの制定、低侵襲療法の採用増加などにより、大きな成長を遂げています。これらの要因が、SCSに対する世界の注目と需要を牽引しています。さらに、座りっぱなしの生活習慣に起因する慢性疼痛の人口の高い有病率が、市場の拡大にさらに寄与しています。現在の市場の活況は、神経刺激技術の採用拡大に後押しされ、将来的にさらなる機会を生み出すと期待されています。

継続的な技術の進歩と政府の指針が脊髄刺激装置市場の成長を促進しています。メーカーは装置の小型化と効率化に注力しており、より高度なインパルス生産の開発につながっています。さらに、政府関連団体は、慢性疼痛やその他の疾患の治療に脊髄刺激療法を使用するための推奨事項やガイドラインを策定しています。国立医療技術評価機構（National Institute for Health and Care Excellence）が発表したガイドラインなどは、市場の活性化と脊髄刺激装置の採用を促しています。

オピオイド依存の軽減を目指す政府の取り組みにより、脊髄刺激装置を含む代替療法への需要が高まっています。米国、欧州、その他の国々の政府は、非オピオイド疼痛管理デバイスの開発と承認を積極的に支援しています。メドトロニック社、アボット社、ボストン・サイエンティフィック社などの医療機器企業は、この市場機会の拡大に対応するため、研究開発に投資しています。

当レポートは、世界の脊髄刺激市場について調査し、市場の概要とともに、技術タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 動向分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標
  • トップ投資分析
  • 主な成功要因
  • 競合の程度

市場力学と展望

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • ポーター分析

世界の脊髄刺激市場、技術別

  • 市場概要
  • 充電式
  • 非充電式

世界の脊髄刺激市場、用途別

  • 市場概要
  • 腰部手術失敗症候群
  • 複合性局所疼痛症候群
  • クモ膜炎
  • 坐骨神経痛
  • 椎間板変性疾患
  • その他

世界の脊髄刺激市場、地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

競合情勢

  • 主要企業プロファイル
    • Medtronic
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Stimwave LLC
    • Nuvectra Corporation
    • Saluda Medical Pty Ltd
    • Synapse Biomedical Inc.
    • NeuroSigma, Inc.
    • Axonics Modulation Technologies, Inc.
    • SPR Therapeutics, Inc
    • Cyberonics, Inc.
    • Inspire Medical Systems, Inc.
    • ReShape Lifesciences Inc
    • LivaNova PLC
    • Integer Holdings Corporation
    • Nevro Corp.
    • Stryker Corporation
    • Zynex, Inc.
    • StimGuard LLC.
目次
Product Code: SQSG35A2012

Spinal Cord Stimulation Market size was valued at USD 3.02 billion in 2021 and is poised to grow from USD 3.25 billion in 2022 to USD 5.83 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).

The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is a neurostimulation device implanted in the body to treat chronic pain. It works by emitting electric signals that block pain signals, providing relief for conditions related to the spinal cord, back, arms, and legs. This therapy is particularly beneficial for patients with chronic pain who have not responded to medication or other traditional treatments.

The global SCS market is experiencing significant growth due to advancements in technology, the establishment of guidelines for SCS procedures, and the increasing adoption of minimally invasive therapies. These factors are driving the attention and demand for SCS globally. Additionally, the high prevalence of chronic pain in the population, attributed to sedentary lifestyles, further contributes to the market's expansion. The current boom in the market is expected to create more opportunities in the future, fueled by the growing adoption of neurostimulation techniques.

Segments covered in this report

Spinal Cord Stimulation Market segmentation is based on technology type, application and region. Based on technology type the market is segmented into rechargeable and non- rechargeable types. Based on application, the market is segregated into failed back surgery syndrome, complex regional pain syndrome, arachnoiditis, sciatica, degenerative disc disease and others. Based on region the Spinal Cord Stimulation Market is segmented into North America, Europe, Asia-Pacific and Rest of the world

Driver

Continuous technological advancements and government guidelines are driving the growth of the spinal cord stimulator market. Manufacturers are focusing on making devices smaller and more efficient, leading to the development of more advanced impulse production. Additionally, government associations are establishing recommendations and guidelines for the use of spinal cord stimulation therapy in treating chronic pain and other conditions. These guidelines, such as those released by the National Institute for Health and Care Excellence, are encouraging market activity and adoption of spinal cord stimulators.

Restraint

The high costs associated with spinal cord stimulator implantation and the uneven distribution of medical services are posing challenges to market growth. The surgery costs can vary significantly depending on factors such as insurance coverage and out-of-pocket expenses. Additionally, the ongoing maintenance expenses and replacement costs further contribute to the financial burden for patients. Moreover, the lack of availability of healthcare equipment in remote locations limits treatment options for the local population, leading to a dependency on larger towns for necessary medical care. These factors are likely to impede the growth of the market.

Market Trends

Government initiatives aimed at reducing opioid dependence have led to an increased demand for alternative therapies, including spinal cord stimulation devices. Governments in the U.S., Europe, and other countries are actively supporting the development and approval of non-opioid pain management devices. Medical device companies like Medtronic, Abbott, and Boston Scientific are investing in research and development to capitalize on this growing market opportunity.

Technological advancements in the field of spinal cord stimulation are also driving market growth. Miniature devices are being developed, and customization techniques such as remote-control options, rechargeable batteries, and wireless connectivity are being incorporated into the devices. These advancements allow for more personalized and convenient treatment options in the healthcare sector.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Spinal Cord Stimulation Market by Technology Type

  • Market Overview
  • Rechargeable
  • Non-Rechargeable

Global Spinal Cord Stimulation Market by Application

  • Market Overview
  • Failed back surgery syndrome
  • Complex Regional Pain Syndrome
  • Arachnoiditis
  • Sciatica
  • Degenerative Disc Disease
  • Others

Global Spinal Cord Stimulation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nuvectra Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saluda Medical Pty Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synapse Biomedical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroSigma, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Axonics Modulation Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SPR Therapeutics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyberonics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inspire Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ReShape Lifesciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • StimGuard LLC.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments